Clinical trial · Observational
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
Obtención de un Panel de puntuación ("Score System") Para la predicción de Riesgo Individualizado y la detección Precoz de Carcinoma Hepatocelular (HCC) en Sujetos Coinfectados VIH/VHC
NCT02113865CI-TRIAL-00017075completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to establish a clinical score panel based on clinical, molecular and genetic parameters that allow us to stratify and obtain an early detection of patients with an increased risk of developing hepatocellular carcinoma (HCC).
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acquired Immunodeficiency Syndrome Virus | — | UNRESOLVED | — |
| Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted | — | UNRESOLVED | — |
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- Grupo 0
- description
- Null or mild fibrosis
- label
- Grupo 1
- description
- Cirrhosis
- label
- Grupo 2
- description
- HCC diagnosis
Primary outcomes (1)
- measure
- Sera inflammatory markers
- timeFrame
- 1 day (Routine visit to normal following in Infectious Disease Department)
- description
- Inflammatory markers will be measure used a Enzyme-linked Immunosorbent Assay
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Human immunodeficiency virus chronic infection * Hepatitis C virus chronic infection * No other liver viral coinfections Exclusion Criteria: * Alcohol consume * Immunosuppressor or immunoactive treatment
References
Publications (0)
Data not yet available
No reference posted for this study.